In the context of liver fibrosis, the EV mechanisms of action include suppression of the expression of TGF-β and of HSC activation, regulation of programmed cell death, and reduction of inflammation, contributing to hepatic regeneration and preservation of tissue integrity. The gene discussed is TGFB1; the disease is Hepatic fibrosis.